Sunshine Biopharma Inc. License Costs (Deprecated 2018-01-31)
Sunshine Biopharma Inc. (SBFM) reported License Costs (Deprecated 2018-01-31) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2018-04-02
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for the quarter ending 2017-12-31 was -$16.80K.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $16.80K, a 77.16% increase year-over-year.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for fiscal 2016 was $19.20K, a 95.01% decline from fiscal 2015.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for fiscal 2015 was $384.58K, a 46.04% increase from fiscal 2014.
- Sunshine Biopharma Inc. license costs (deprecated 2018-01-31) for fiscal 2014 was $263.33K, a 44.56% decline from fiscal 2013.
| Period end | License Costs (Deprecated 2018-01-31) 3 month | License Costs (Deprecated 2018-01-31) 3 month as first filed | License Costs (Deprecated 2018-01-31) 6 month | License Costs (Deprecated 2018-01-31) 6 month as first filed | License Costs (Deprecated 2018-01-31) 9 month | License Costs (Deprecated 2018-01-31) 9 month as first filed | License Costs (Deprecated 2018-01-31) 12 month | License Costs (Deprecated 2018-01-31) 19 month | License Costs (Deprecated 2018-01-31) 22 month | License Costs (Deprecated 2018-01-31) 25 month | License Costs (Deprecated 2018-01-31) 28 month | License Costs (Deprecated 2018-01-31) 31 month | License Costs (Deprecated 2018-01-31) 34 month | License Costs (Deprecated 2018-01-31) 37 month | License Costs (Deprecated 2018-01-31) 40 month | License Costs (Deprecated 2018-01-31) 43 month | License Costs (Deprecated 2018-01-31) 46 month | License Costs (Deprecated 2018-01-31) 49 month | License Costs (Deprecated 2018-01-31) 55 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$16.80K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 derived: sum of 3 quarters · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | |||||||||||||||
| 2017-09-30 | $16.80K 10-Q · filed 2017-11-15 | $16.80K derived: sum of 2 quarters · filed 2017-11-15 | $16.80K 10-Q · filed 2017-11-15 | -$17.27K derived: sum of 4 quarters · filed 2018-04-02 | |||||||||||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | -$34.07K derived: sum of 3 quarters · filed 2018-04-02 | -$24.59K derived: sum of 4 quarters · filed 2018-04-02 | |||||||||||||||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-04-02 | -$34.07K derived: sum of 2 quarters · filed 2018-04-02 | -$24.59K derived: sum of 3 quarters · filed 2018-04-02 | -$16.82K derived: sum of 4 quarters · filed 2018-04-02 | |||||||||||||||
| 2016-12-31 | -$34.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$24.59K derived: sum of 2 quarters · filed 2018-04-02 | -$16.82K derived: sum of 3 quarters · filed 2018-04-02 | $19.20K 10-K · filed 2018-04-02 | |||||||||||||||
| 2016-09-30 | $9.48K 10-Q · filed 2017-11-15 | $0.00 10-Q · filed 2016-11-14 | $17.24K derived: sum of 2 quarters · filed 2017-11-15 | $53.27K 10-Q · filed 2017-11-15 | $0.00 10-Q · filed 2016-11-14 | $142.73K derived: sum of 4 quarters · filed 2017-11-15 | |||||||||||||
| 2016-06-30 | $7.76K 10-Q · filed 2017-08-11 | $7.76K 10-Q · filed 2017-08-11 | $133.25K derived: sum of 3 quarters · filed 2017-08-11 | $198.23K derived: sum of 4 quarters · filed 2017-08-11 | |||||||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $125.49K derived: sum of 2 quarters · filed 2017-04-17 | $190.47K derived: sum of 3 quarters · filed 2017-04-17 | $334.58K derived: sum of 4 quarters · filed 2017-04-17 | |||||||||||||||
| 2015-12-31 | $125.49K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $190.47K derived: sum of 2 quarters · filed 2017-04-17 | $334.58K derived: sum of 3 quarters · filed 2017-04-17 | $384.58K 10-K · filed 2017-04-17 | |||||||||||||||
| 2015-09-30 | $64.99K 10-Q · filed 2016-11-14 | $209.09K derived: sum of 2 quarters · filed 2016-11-14 | $259.09K 10-Q · filed 2016-11-14 | $339.09K derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||||
| 2015-06-30 | $144.11K 10-Q · filed 2016-08-16 | $194.11K 10-Q · filed 2016-08-16 | $274.11K derived: sum of 3 quarters · filed 2016-08-16 | $304.11K derived: sum of 4 quarters · filed 2016-08-16 | |||||||||||||||
| 2015-03-31 | $50.00K 10-Q · filed 2016-05-09 | $130.00K derived: sum of 2 quarters · filed 2016-05-09 | $160.00K derived: sum of 3 quarters · filed 2016-05-09 | $230.00K derived: sum of 4 quarters · filed 2016-05-09 | |||||||||||||||
| 2014-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $110.00K derived: sum of 2 quarters · filed 2016-03-25 | $180.00K derived: sum of 3 quarters · filed 2016-03-25 | $263.33K 10-K · filed 2016-03-25 | |||||||||||||||
| 2014-09-30 | $30.00K 10-Q · filed 2015-11-04 | $100.00K derived: sum of 2 quarters · filed 2015-11-04 | $183.33K 10-Q · filed 2015-11-04 | $283.33K derived: sum of 4 quarters · filed 2015-11-04 | |||||||||||||||
| 2014-06-30 | $70.00K 10-Q · filed 2015-08-06 | $153.33K 10-Q · filed 2015-08-06 | $253.33K derived: sum of 3 quarters · filed 2015-08-06 | $303.33K derived: sum of 4 quarters · filed 2015-08-06 | |||||||||||||||
| 2014-03-31 | $83.33K 10-Q · filed 2015-05-07 | $183.33K derived: sum of 2 quarters · filed 2015-05-07 | $233.33K derived: sum of 3 quarters · filed 2015-05-07 | $238.99K derived: sum of 4 quarters · filed 2015-05-07 | $1.26M 10-Q · filed 2014-05-09 | ||||||||||||||
| 2013-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $150.00K derived: sum of 2 quarters · filed 2015-03-11 | $155.66K derived: sum of 3 quarters · filed 2015-03-11 | $475.00K 10-K · filed 2015-03-11 | $1.18M 10-K · filed 2014-03-19 | ||||||||||||||
| 2013-09-30 | $50.00K 10-Q · filed 2014-11-12 | $55.66K derived: sum of 2 quarters · filed 2014-11-12 | $375.00K 10-Q · filed 2014-11-12 | $455.65K derived: sum of 4 quarters · filed 2014-11-12 | $1.07M 10-Q · filed 2013-11-04 | ||||||||||||||
| 2013-06-30 | $5.66K 10-Q · filed 2014-08-12 | $325.00K 10-Q · filed 2014-08-12 | $405.65K derived: sum of 3 quarters · filed 2014-08-12 | $505.65K derived: sum of 4 quarters · filed 2014-08-12 | $1.02M 10-Q · filed 2013-08-06 | ||||||||||||||
| 2013-03-31 | $250.00K 10-Q · filed 2014-05-09 | $400.00K derived: sum of 2 quarters · filed 2014-05-09 | $500.00K derived: sum of 3 quarters · filed 2014-05-09 | $500.00K derived: sum of 4 quarters · filed 2014-05-09 | $950.00K 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $250.00K derived: sum of 2 quarters · filed 2014-03-19 | $250.00K derived: sum of 3 quarters · filed 2014-03-19 | $250.00K 10-K · filed 2014-03-19 | $700.00K 10-K · filed 2013-03-15 | ||||||||||||||
| 2012-09-30 | $100.00K 10-Q · filed 2012-11-08 | $100.00K derived: sum of 2 quarters · filed 2012-11-08 | $100.00K 10-Q · filed 2013-11-04 | $200.00K derived: sum of 4 quarters · filed 2013-03-15 | $550.00K 10-Q · filed 2012-11-08 | ||||||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-08 | $0.00 10-Q · filed 2012-08-08 | $100.00K derived: sum of 3 quarters · filed 2013-03-15 | $200.00K derived: sum of 4 quarters · filed 2013-03-15 | $450.00K 10-Q · filed 2012-08-08 | ||||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 | $100.00K derived: sum of 2 quarters · filed 2013-03-15 | $200.00K derived: sum of 3 quarters · filed 2013-03-15 | $200.00K derived: sum of 4 quarters · filed 2013-03-15 | $450.00K 10-Q · filed 2012-05-08 | ||||||||||||||
| 2011-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $200.00K derived: sum of 2 quarters · filed 2013-03-15 | $200.00K derived: sum of 3 quarters · filed 2013-03-15 | $200.00K 10-K · filed 2013-03-15 | $450.00K 10-K · filed 2012-03-19 | ||||||||||||||
| 2011-09-30 | $100.00K 10-Q · filed 2012-11-08 | $100.00K derived: sum of 2 quarters · filed 2012-11-08 | $100.00K 10-Q · filed 2012-11-08 | $350.00K derived: sum of 4 quarters · filed 2012-11-08 | $350.00K 10-Q · filed 2011-11-08 | ||||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-08 | $15.12K 10-Q · filed 2012-08-08 | $0.00 10-Q · filed 2011-08-09 | $250.00K derived: sum of 3 quarters · filed 2012-08-08 | $250.00K derived: sum of 4 quarters · filed 2012-08-08 | $3.00K 10-Q · filed 2011-08-09 | |||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-08 | $250.00K derived: sum of 2 quarters · filed 2012-05-08 | $250.00K derived: sum of 3 quarters · filed 2012-05-08 | $250.00K derived: sum of 4 quarters · filed 2012-05-08 | $250.00K 10-Q · filed 2011-05-12 | ||||||||||||||
| 2010-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-19 | $250.00K derived: sum of 2 quarters · filed 2012-03-19 | $250.00K derived: sum of 3 quarters · filed 2012-03-19 | $250.00K 10-K · filed 2012-03-19 | |||||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-08 | $0.00 derived: sum of 2 quarters · filed 2011-11-08 | $0.00 10-Q · filed 2011-11-08 | ||||||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | $0.00 10-Q · filed 2011-08-09 | |||||||||||||||||
| 2010-03-31 | $0.00 10-Q · filed 2011-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |